amiodarone has been researched along with Coronavirus Infections in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Coronavirus Infections: Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)." | 3.96 | Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? ( Laukkanen, JA; Lavie, CJ; Morin, DP; Perez, MV; Perez-Quilis, C; Sanchis-Gomar, F, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaugeois, JM | 1 |
| Navarese, EP | 1 |
| Musci, RL | 1 |
| Frediani, L | 1 |
| Gurbel, PA | 1 |
| Kubica, J | 1 |
| Sanchis-Gomar, F | 1 |
| Lavie, CJ | 1 |
| Morin, DP | 1 |
| Perez-Quilis, C | 1 |
| Laukkanen, JA | 1 |
| Perez, MV | 1 |
| Baldi, E | 1 |
| Sechi, GM | 1 |
| Mare, C | 1 |
| Canevari, F | 1 |
| Brancaglione, A | 1 |
| Primi, R | 1 |
| Palo, A | 1 |
| Contri, E | 1 |
| Ronchi, V | 1 |
| Beretta, G | 1 |
| Reali, F | 1 |
| Parogni, PP | 1 |
| Facchin, F | 1 |
| Rizzi, U | 1 |
| Bussi, D | 1 |
| Ruggeri, S | 1 |
| Oltrona Visconti, L | 1 |
| Savastano, S | 1 |
1 review available for amiodarone and Coronavirus Infections
| Article | Year |
|---|---|
Ion channel inhibition against COVID-19: A novel target for clinical investigation.
Topics: Amiodarone; Communicable Disease Control; Coronavirus Infections; COVID-19; Female; Humans; Ion Chan | 2020 |
3 other studies available for amiodarone and Coronavirus Infections
| Article | Year |
|---|---|
Psychotropics drugs with cationic amphiphilic properties may afford some protection against SARS-CoV-2: A mechanistic hypothesis.
Topics: Amiodarone; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; | 2020 |
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Topics: Amiodarone; Angiotensin-Converting Enzyme 2; Anti-Arrhythmia Agents; Antiviral Agents; Arrhythmias, | 2020 |
Treatment of out-of-hospital cardiac arrest in the COVID-19 era: A 100 days experience from the Lombardy region.
Topics: Aged; Aged, 80 and over; Amiodarone; Betacoronavirus; Cardiopulmonary Resuscitation; Coronavirus Inf | 2020 |